Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of RadioFrequency Endoscopic ABlation, With ULtrasound Guidance, as a Non-surgical, Adrenal Sparing Treatment for Aldosterone-producing Adenomas

NCT03405025 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03405025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of RadioFrequency Endoscopic ABlation, With ULtrasound Guidance, as a Non-surgical, Adrenal Sparing Treatment for Aldosterone-producing Adenomas
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Completed
Start date
February 21, 2018
Completion date
May 10, 2023
Enrollment
28 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperaldosteronism, primary hyperaldosteronism due to adrenal adenoma